Login

$SOLV SEC Filings

Filed On Filing
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

EAGAN, Minn., November 5, 2026 – Solventum (NYSE: SOLV) today reported financial results for the third quarter ended September 30, 2026.

03 Sep 2026 Form 4: Hanson Bryan C, Director

Received 67,261 shares by exercise or conversion · Gave up 26,468 shares to cover exercise price or tax ($2.41M)

18 Aug 2026 Form 4: Zieselman Neil Craig, SVP, Controller & CAO

Granted 6,911 Restricted Stock Units

18 Aug 2026 Form 3: Zieselman Neil Craig, SVP, Controller & CAO

No securities owned

05 Aug 2026 10-Q
05 Aug 2026 8-K: Results of Operations and Financial Condition

EAGAN, Minn., August 5, 2026 – Solventum (NYSE: SOLV) today reported financial results for the second quarter ended June 30, 2026.

05 Aug 2026 8-K: Regulation FD Disclosure; Other Events

EAGAN, Minn., Aug. 5, 2026 — Solventum (NYSE: SOLV) today announced its intention to pursue a separation of its Health Information Systems business as part of the company's ongoing portfolio optimization strategy. The company will evalua...

20 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation

On July 16, 2026, the Board of Directors of Solventum Corporation (the “Company”) appointed Neil Zieselman to serve as Senior Vice President, Controller and Chief Accounting Officer of the Company, effective as of August 10, 2026. Mr. Zi...

05 Jun 2026 8-K: Other Events

WHEREAS, on May 10, 2024, Plaintiff Eric Gilbert (“Plaintiff”) filed a Verified Class Action Complaint (the “Complaint”) against, Defendant Solventum Corporation (“Defendant”).

29 May 2026 SD
27 May 2026 8-K: Departure/Election of Directors or Officers; Compensation

The purpose and intent of this Solventum Executive Severance Plan (“Plan”) is to provide separation benefits to certain eligible employees of Solventum Corporation (“Solventum”) or an affiliate of Solventum participating in the Plan (eac...

20 May 2026 8-K: Submission of Matters to a Vote of Security Holders

Solventum Corporation (“Solventum”) held its annual meeting of shareholders on May 15, 2026. Set forth below are the final voting results for each of the matters submitted to a vote of the shareholders. For more information about the pro...

18 May 2026 Form 4: Alban Carlos, Director

Granted 3,300 Restricted Stock Units

18 May 2026 Form 4: Cox Carrie Smith, Director

Granted 4,848 Restricted Stock Units

18 May 2026 Form 4: DeVore Susan D., Director

Granted 3,300 Restricted Stock Units

18 May 2026 Form 4: Edwards Shirley Ann, Director

Granted 3,300 Restricted Stock Units

18 May 2026 Form 4: Eisenberg Glenn A, Director

Granted 3,300 Restricted Stock Units

18 May 2026 Form 4: Harris Bernard A Jr, Director

Granted 3,300 Restricted Stock Units

18 May 2026 Form 4: May Karen J, Director

Granted 3,300 Restricted Stock Units

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support